Publication not explained
Read the Original
This page is a summary of: DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells, British Journal of Cancer, March 2018, Springer Science + Business Media, DOI: 10.1038/s41416-018-0025-x.
You can read the full text:
The following have contributed to this page